Table 2.
Characteristics | CMUSE | SBCD | P valua | ||
---|---|---|---|---|---|
N | n(%) | N | n(%) | ||
Number of patients underwent CTE | 14 | 12 (85.7) | 61 | 35 (57.4) | / |
Skip lesions | 12 | 8 (66.7) | 35 | 20 (57.1) | 0.811 |
Enteric findings | 12 | 10 (83.3) | 35 | 32 (91.4) | 0.808 |
Ulcers | 12 | 0 (0.0) | 35 | 2 (5.7) | 1.000 |
Bowel strictures | 12 | 8 (66.7) | 35 | 13 (37.1) | 0.076 |
Bowel wall thickening | 12 | 10 (83.3) | 35 | 30 (85.7) | 1.000 |
Mural hyperenhancement | 12 | 7 (58.3) | 35 | 29 (82.9) | 0.181 |
Roughness of serosa | 12 | 0 (0.0) | 35 | 8 (22.9) | 0.170 |
Pseudodiverticulum | 12 | 1 (8.3) | 35 | 5 (14.3) | 1.000 |
Pseudo-polyps | 12 | 0 (0.0) | 35 | 2 (5.7) | 1.000 |
Extra-enteric findings | 12 | 3 (25.0) | 35 | 25 (71.4) | 0.013 |
Comb sign | 12 | 1 (8.3) | 35 | 3 (8.6) | 1.000 |
Enhanced density of the peri-intestinal fat | 12 | 0 (0.0) | 35 | 5 (14.3) | 0.309 |
Enlarged lymph nodes | 12 | 2 (16.7) | 35 | 21 (60.0) | 0.010 |
Fistula | 12 | 0 (0.0) | 35 | 4 (11.4) | 0.560 |
CMUSE cryptogenic multifocal ulcerous stenosing enteritis; SBCD small bowel Crohn’s disease; CTE computed tomography enterography